Xenon Pharmaceuticals Inc.
NASDAQ:XENE
35.18 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| -234.33 | -182.393 | -125.373 | -78.882 | -28.837 | -41.595 | -34.497 | -30.704 | -22.997 | -15.752 | 13.018 | 12.032 | -4.301 | -11.992 |
| Depreciation & Amortization
| 0 | 3.541 | 1.624 | 0.906 | 0.644 | 0.429 | 0.586 | 0.649 | 0.864 | 1.038 | 0.738 | 0.705 | 0.786 | 1.132 |
| Deferred Income Tax
| -8.864 | -0.292 | -0.044 | 0.058 | -0.285 | -0.133 | 0.646 | -1.474 | -1.3 | 6.902 | 0.072 | 0.083 | 0.996 | -0.088 |
| Stock Based Compensation
| 50.717 | 32.372 | 20.376 | 10.017 | 5.677 | 2.924 | 2.625 | 2.236 | 2.161 | 3.729 | 0.76 | 0.648 | 0.414 | 0.447 |
| Change In Working Capital
| 0 | 5.635 | -0.676 | -2.647 | -26.089 | 33.52 | 0.03 | 0.556 | 1.768 | -13.957 | -14.256 | -16.675 | 47.418 | -3.266 |
| Accounts Receivables
| 0 | 0.13 | 1.757 | -0.459 | -1.032 | -0.653 | 0.175 | -0.232 | 0.121 | -0.107 | 0.209 | -0.076 | 11.23 | -11.008 |
| Inventory
| 0 | 0 | 0 | -2.971 | -2.022 | -4.541 | -0.783 | 0.613 | 0.571 | 0 | -0.573 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 3.931 | 8.062 | 2.971 | 2.022 | 4.541 | 0.783 | -0.003 | 0.547 | 0.08 | 0.518 | 0 | 0 | 0 |
| Other Working Capital
| 6.327 | 1.574 | -10.495 | -2.188 | -25.057 | 34.173 | -0.145 | 0.178 | 0.529 | -13.85 | -14.41 | -16.599 | 36.188 | 7.742 |
| Other Non Cash Items
| 11.088 | -4.19 | 5.663 | 1.046 | 0.766 | 0.223 | -4.114 | 0.011 | -0.063 | -0.063 | -0.066 | -0.115 | 0.26 | 0.078 |
| Operating Cash Flow
| -181.389 | -145.327 | -98.43 | -69.502 | -48.124 | -4.632 | -34.724 | -28.726 | -19.567 | -18.103 | 0.266 | -3.322 | 45.573 | -13.689 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| 0 | -5.617 | -2.894 | -2.05 | -2.637 | -1.24 | -0.507 | -0.315 | -0.279 | -0.551 | -1.529 | -0.156 | -0.526 | -0.29 |
| Acquisitions Net
| 0 | 0 | 296.003 | -144.754 | -214.71 | -75.443 | -48.522 | -52.616 | 0 | 0 | -13.539 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -793.907 | -551.137 | -389.474 | -228.897 | -140.494 | -77.002 | -28.007 | -47.563 | 0 | -15.254 | -17.876 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 682.354 | 258.028 | 144.754 | 214.71 | 75.443 | 48.522 | 52.616 | 0 | 10.745 | 13.539 | 6.55 | 1.01 | 14.179 |
| Other Investing Activites
| 165 | 0 | -296.003 | 144.754 | 214.71 | 75.443 | 48.522 | 52.616 | -47.563 | 10.745 | 13.539 | 0.01 | 0.007 | 0 |
| Investing Cash Flow
| 165 | -117.17 | -296.003 | -246.77 | -16.824 | -66.291 | -28.987 | 24.294 | -47.842 | 10.194 | -3.244 | -11.472 | 0.491 | 13.889 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -16.743 | 0 | 8.453 | 6.893 | 0 | 0 | 0 | -1.701 | 0 | 0 |
| Common Stock Issued
| 12.083 | 353.487 | 277.766 | 447.283 | 102.456 | 27.396 | 102.85 | 0.177 | 23.832 | 0.278 | 42.644 | 0.049 | 0 | 0.002 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.047 | 0.035 | 0.705 | 0.26 | 0.082 | 0.122 | 0.288 | 0.177 | 0.132 | 0 | -1.52 | -2.739 | 0 | 0 |
| Financing Cash Flow
| 12.13 | 353.522 | 278.471 | 447.543 | 85.795 | 27.518 | 111.591 | 7.07 | 23.964 | 0.278 | 41.124 | -4.391 | 0 | 0.002 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| -1.672 | 0.376 | -2.484 | -0.592 | -0.593 | 0.406 | -0.612 | 0.753 | 1.889 | -5.744 | -4.07 | -3.027 | 0.17 | -0.314 |
| Net Change In Cash
| -5.931 | 91.401 | -118.446 | 130.679 | 20.254 | -42.999 | 47.268 | 3.391 | -41.556 | -13.375 | 34.076 | -22.212 | 46.234 | -0.112 |
| Cash At End Of Period
| 142.712 | 148.643 | 57.242 | 175.688 | 45.009 | 24.755 | 67.754 | 20.486 | 17.095 | 58.651 | 72.026 | 37.95 | 60.162 | 13.928 |